Publications by authors named "Mathilde Cosson"
Background: This article looks at the behaviour of women facing different cancer screening options available to them from the age of 50 onward. The study was conducted in 2019 in four departments of the French territory with the objective of identifying the factors that influence acceptance of a population-based screening proposal.
Methods: A questionnaire was sent to women who had received three invitations to organised screenings (OS) for both breast and colorectal cancer.
Background: Today, women 50 years of age are offered three types of cancer screening in France. However, participation is not optimal. The aim was to describe (1) participation in organised breast cancer screening (OS) of women aged 56 years old, and the influence of this participation on colorectal and cervical cancer screening, (2) the reasons for non-participation in breast cancer OS, and (3) the reasons for screening before age 50.
View Article and Find Full Text PDFBackground And Aims: We aimed to evaluate the effects of switching to faecal immunochemical testing (FIT) on the cumulative 2-year incidence rate of interval cancers, interval cancer rate and test sensitivity within a mature population-based colorectal cancer screening programme consisting of six rounds of biennial guaiac faecal occult blood testing (gFOBT).
Methods: The FIT results were compared with those of gFOBT used in each of the previous two rounds. For the three rounds analysed, 279,041 tests were performed by 156,186 individuals.
Article Synopsis
- This study looked at how patients with very early colorectal cancer were monitored with medical imaging after their treatment.
- Out of 450 patients, only about 35% had imaging follow-ups, and those with stage 1 cancer were monitored way more than those with stage 0.
- The research found that the doctor in charge and the type of surgery the patient had greatly affected whether they got follow-up imaging, suggesting some patients might be checked too much when it isn't really needed.
Article Synopsis
- Researchers studied a type of cancer called intramucosal carcinoma (IMC) to find out how it compares to another type called T1 colorectal cancer (CRC).
- They looked at data from 282 IMC cases and 207 T1 CRC cases found during health screenings.
- The results showed that IMCs are generally easier to treat, have better outcomes, and show less severe complications than T1 CRCs.
Aim: The main aim of this study was to examine the management strategies that were used and to determine the outcomes (survival and recurrence rate) of screen-detected T1-CRC.
Methods: Medical records from 207 patients with T1-CRC diagnosed through the French national screening programme in one district from 2003 to 2015 were analysed. The 5-year overall, CRC-specific and CRC-free survival were calculated for the whole cohort and for the 3 groups treated by endoscopic resection (ER) alone, ER followed by subsequent surgery (ERSS), and primary surgery (PS).
Background: Compared with the guaiac-faecal occult blood test (gFOBT), faecal immunological tests (FIT) are considered to be more effective for colorectal cancer (CRC) screening. However, only scarce research has examined the outcomes of switching to FIT within a mature gFOBT-based CRC screening programme.
Methods: We reported a 15-year experience of biennial FOBT screening in a well-defined population of approximately one million inhabitants, including six gFOBT-based screening rounds and one round with FIT at the 30 μg Hb/g cut-off.